Medexus Pharmaceutical's ticker is MEDXF and the CUSIP is 58410Q203. A total of 1 filers reported holding Medexus Pharmaceutical in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $88,000 | +76.0% | 35,000 | +40.0% | 0.03% | +80.0% |
| Q4 2021 | $50,000 | -24.2% | 25,000 | -10.7% | 0.02% | +66.7% |
| Q3 2021 | $66,000 | -44.1% | 28,000 | +40.0% | 0.01% | -47.1% |
| Q2 2021 | $118,000 | +34.1% | 20,000 | +42.9% | 0.02% | +30.8% |
| Q1 2021 | $88,000 | +63.0% | 14,000 | +40.0% | 0.01% | +44.4% |
| Q4 2020 | $54,000 | +86.2% | 10,000 | 0.0% | 0.01% | +80.0% |
| Q3 2020 | $29,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Whitegate Investment Counselors, Inc. | 25,000 | $50,000 | 0.02% |